+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cell Therapy Technologies Global Market Report 2024

  • PDF Icon

    Report

  • 200 Pages
  • February 2024
  • Region: Global
  • The Business Research Company
  • ID: 5939209
The cell therapy technologies market size has grown rapidly in recent years. It will grow from $4.29 billion in 2023 to $4.97 billion in 2024 at a compound annual growth rate (CAGR) of 15.8%. Historical growth can be attributed to several factors, including robust economic expansion in emerging markets, a rise in healthcare expenditure, increased government investments in cell-based research, and a heightened demand for personalized medicine.

The cell therapy technologies market size is expected to see rapid growth in the next few years. It will grow to $8.62 billion in 2028 at a compound annual growth rate (CAGR) of 14.8%. Forecasted growth is driven by an aging population, increased cancer prevalence, higher R&D spending in pharmaceuticals, and advancements in cell therapies. Major trends include innovating products, leveraging advanced tech, developing novel cell therapies, investing in manufacturing, and fostering partnerships.

The global cell therapy technologies market has experienced growth, driven by increasing government investments in cell-based research. Governments are allocating funds to support research activities focused on developing therapies for various diseases, including cancer, cardiovascular disease (CVD), and more. An example of this investment trend is observed in the actions of The California Institute for Regenerative Medicine (CIRM), a research center dedicated to stem cell research. In May 2022, CIRM invested over $11 million to fund a clinical trial for a cell therapy designed to treat throat cancer. The success of this therapy could potentially spare patients from undergoing radiotherapy and its associated side effects.

The prevalence of cancer has become a significant factor contributing to the growth of the cell therapy technologies market. Cell therapy, which utilizes living cells as drugs to treat diseases, particularly leverages the immune system's inherent capability to seek out and destroy abnormal cells in the body when applied to cancer treatment. According to the American Cancer Society, it is estimated that the USA will see a total of 1.9 million new cancer cases and 609,360 deaths from cancer in 2022, equating to approximately 1,670 deaths daily. Additionally, projections from the International Agency for Research on Cancer indicate that by 2040, the annual number of new cancer cases is expected to rise to 29.5 million, with cancer-related deaths reaching 16.4 million. The increasing prevalence of cancer cases is anticipated to be a significant driver for the growth of the cell therapy technologies market in the forecast period.

Major companies are focusing on developing innovative products using advanced technologies to achieve growth in the dynamic landscape of the cell therapy technologies market. An illustrative example of this trend is seen in the actions of Invetech, an Australia-based company specializing in the design, engineering, and manufacture of commercial-scale diagnostic products and cell and gene therapies. In June 2022, Invetech launched Korus, a novel closed system for autologous cell therapies. Korus is designed to redefine industry standards in elutriation and cell wash by utilizing a mild elutriation process that provides a cleaner cell population for various cell therapy production processes, such as tumor-infiltrated lymphocytes (TIL), dendritic cells, chimeric antigen receptor (CAR)-T cells, or induced pluripotent stem cell (IPSC)-derived therapy. The technology features elutriation and cell wash using gentle counterflow centrifugation, resulting in purified cell populations for downstream processing development and commercial manufacture. Korus aims to enhance overall process performance through improved recovery and purity of target cells, enabling developers to expedite clinical development and scale-up of their products.

Product innovation remains a key focus in the cell therapy technologies market, with companies striving to develop cutting-edge products to solidify their market positions. In September 2022, denovoMATRIX GmbH, a Germany-based innovator in cell and gene therapy manufacturing, launched animal component-free cell culture product lines at cell therapy grade (CTG). These product lines are equipped with documentation and traceability information to comply with industry regulatory standards, catering to the stem cell therapy manufacturing market. Additionally, in December 2021, Novartis, a Switzerland-based pharmaceutical corporation, introduced T-Charge, its next-generation CAR-T platform. T-Charge serves as the foundation for various new investigational CAR-T cell therapies in the Novartis pipeline. The platform preserves T cell stemness, enhancing proliferative potential and reducing exhausted T cells in the product. With T-Charge, CAR-T cell expansion primarily occurs within a patient’s body (in-vivo), eliminating the need for extended culture time outside the body (ex-vivo). These unique characteristics contribute to better and more durable therapeutic responses, improved long-term outcomes, and a reduced risk of severe adverse events.

In July 2022, Evotec, a German biotechnology company, acquired Rigenerand Srl for an undisclosed sum. This acquisition integrates Rigenerand, a cutting-edge cell technology firm specializing in cGMP (current good manufacturing practice) production of cell therapies based in Medolla, Italy, which will now operate under the name Evotec (Modena) Srl. Rigenerand Srl originally hails from Italy and is focused on advanced cell technology.

Major companies operating in the cell therapy technologies market report are Lonza Group AG, Thermo Fisher Scientific Inc., Merck KGaA, Terumo Corporation, Danaher Corporation, Fresenius Medical Care AG & Co. KGaA, Fujifilm Holdings Corporation, Sartorius AG, Becton Dickinson and Company, Avantor Inc., Cellular Biomedicine Group, CORESTEM, Astellas Pharma Inc., Anterogen Co. Ltd., Arce Therapeutics, CARsgen Therapeutics, Huadong Medicine, Co.Don AG, AstraZeneca, Neogene Therapeutics, GammaDelta Therapeutics Limited, Nightstar, SOTIO, Accell Clinical Research, Genestack, Novartis AG, Pfizer, Celgene Corporation, Johnson & Johnson, F. Hoffmann-La Roche Ltd., Bayer AG, Gilead Sciences, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Amgen, Regen BioPharma, Bellicum, Amgen Brazil, GlaxoSmithKline PLC, Biogen Brazil, Takeda Pharmaceutical Company Limited, Pfizer S.R.L, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Bayer East Africa Ltd., Adcock Ingram, Next BioSciences, CryoSave, BioHeart, Stem Cell Technologies.

North America was the largest region in the cell therapy technologies market in 2023. Asia-Pacific is predicted to record the fastest growth over the forecast period. The regions covered in the cell therapy technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cell therapy technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The primary product categories encompass consumables, equipment, systems, and software. Consumables refer to items intended for depletion or use during regular application. They find application across various cell types such as T-cells, stem cells, and others. Processes within cell therapy technologies include cell processing, preservation, distribution, handling, process monitoring, and quality control. These technologies have diverse applications spanning life science companies, research institutes, and cell banks.

The cell therapy technologies market research report is one of a series of new reports that provides cell therapy technologies market statistics, including cell therapy technologies industry global market size, regional shares, competitors with a cell therapy technologies market share, detailed cell therapy technologies market segments, market trends, and opportunities, and any further data you may need to thrive in the cell therapy technologies industry. This cell therapy technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell therapy market consists of sales of cell therapy technologies that are medicinal solutions used for developing and improving cell therapy, such as cell processing, cell banking, and point-of-care technologies. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.


The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary2. Cell Therapy Technologies Market Characteristics3. Cell Therapy Technologies Market Trends and Strategies
4. Cell Therapy Technologies Market - Macro Economic Scenario
4.1. Impact of High Inflation on the Market
4.2. Ukraine-Russia War Impact on the Market
4.3. COVID-19 Impact on the Market
5. Global Cell Therapy Technologies Market Size and Growth
5.1. Global Cell Therapy Technologies Market Drivers and Restraints
5.1.1. Drivers of the Market
5.1.2. Restraints of the Market
5.2. Global Cell Therapy Technologies Historic Market Size and Growth, 2018-2023, Value ($ Billion)
5.3. Global Cell Therapy Technologies Forecast Market Size and Growth, 2023-2028, 2033F, Value ($ Billion)
6. Cell Therapy Technologies Market Segmentation
6.1. Global Cell Therapy Technologies Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Consumables
  • Equipment
  • Systems & Software
6.2. Global Cell Therapy Technologies Market, Segmentation by Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • T-cells
  • Stem Cells
  • Other Cells
6.3. Global Cell Therapy Technologies Market, Segmentation by Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cell Processing
  • Cell Preservation, Distribution, and Handling
  • Process Monitoring and Quality Control
6.4. Global Cell Therapy Technologies Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Life Science Companies
  • Research Institutes
7. Cell Therapy Technologies Market Regional and Country Analysis
7.1. Global Cell Therapy Technologies Market, Split by Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Cell Therapy Technologies Market, Split by Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Cell Therapy Technologies Market
8.1. Asia-Pacific Cell Therapy Technologies Market Overview
Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cell Therapy Technologies Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Cell Therapy Technologies Market, Segmentation by Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Cell Therapy Technologies Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Cell Therapy Technologies Market
9.1. China Cell Therapy Technologies Market Overview
9.2. China Cell Therapy Technologies Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Cell Therapy Technologies Market, Segmentation by Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Cell Therapy Technologies Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Cell Therapy Technologies Market
10.1. India Cell Therapy Technologies Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Cell Therapy Technologies Market, Segmentation by Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Cell Therapy Technologies Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Cell Therapy Technologies Market
11.1. Japan Cell Therapy Technologies Market Overview
11.2. Japan Cell Therapy Technologies Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Cell Therapy Technologies Market, Segmentation by Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Cell Therapy Technologies Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Cell Therapy Technologies Market
12.1. Australia Cell Therapy Technologies Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Cell Therapy Technologies Market, Segmentation by Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Cell Therapy Technologies Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Cell Therapy Technologies Market
13.1. Indonesia Cell Therapy Technologies Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Cell Therapy Technologies Market, Segmentation by Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Cell Therapy Technologies Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Cell Therapy Technologies Market
14.1. South Korea Cell Therapy Technologies Market Overview
14.2. South Korea Cell Therapy Technologies Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Cell Therapy Technologies Market, Segmentation by Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Cell Therapy Technologies Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Cell Therapy Technologies Market
15.1. Western Europe Cell Therapy Technologies Market Overview
15.2. Western Europe Cell Therapy Technologies Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Cell Therapy Technologies Market, Segmentation by Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Cell Therapy Technologies Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Cell Therapy Technologies Market
16.1. UK Cell Therapy Technologies Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Cell Therapy Technologies Market, Segmentation by Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Cell Therapy Technologies Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Cell Therapy Technologies Market
17.1. Germany Cell Therapy Technologies Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Cell Therapy Technologies Market, Segmentation by Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Cell Therapy Technologies Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Cell Therapy Technologies Market
18.1. France Cell Therapy Technologies Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Cell Therapy Technologies Market, Segmentation by Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Cell Therapy Technologies Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Cell Therapy Technologies Market
19.1. Italy Cell Therapy Technologies Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Cell Therapy Technologies Market, Segmentation by Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Cell Therapy Technologies Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Cell Therapy Technologies Market
20.1. Spain Cell Therapy Technologies Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Cell Therapy Technologies Market, Segmentation by Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Cell Therapy Technologies Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Cell Therapy Technologies Market
21.1. Eastern Europe Cell Therapy Technologies Market Overview
21.2. Eastern Europe Cell Therapy Technologies Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Cell Therapy Technologies Market, Segmentation by Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Cell Therapy Technologies Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Cell Therapy Technologies Market
22.1. Russia Cell Therapy Technologies Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Cell Therapy Technologies Market, Segmentation by Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Cell Therapy Technologies Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Cell Therapy Technologies Market
23.1. North America Cell Therapy Technologies Market Overview
23.2. North America Cell Therapy Technologies Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Cell Therapy Technologies Market, Segmentation by Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Cell Therapy Technologies Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Cell Therapy Technologies Market
24.1. USA Cell Therapy Technologies Market Overview
24.2. USA Cell Therapy Technologies Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Cell Therapy Technologies Market, Segmentation by Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Cell Therapy Technologies Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Cell Therapy Technologies Market
25.1. Canada Cell Therapy Technologies Market Overview
25.2. Canada Cell Therapy Technologies Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Cell Therapy Technologies Market, Segmentation by Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Cell Therapy Technologies Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Cell Therapy Technologies Market
26.1. South America Cell Therapy Technologies Market Overview
26.2. South America Cell Therapy Technologies Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Cell Therapy Technologies Market, Segmentation by Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Cell Therapy Technologies Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Cell Therapy Technologies Market
27.1. Brazil Cell Therapy Technologies Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Cell Therapy Technologies Market, Segmentation by Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Cell Therapy Technologies Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Cell Therapy Technologies Market
28.1. Middle East Cell Therapy Technologies Market Overview
28.2. Middle East Cell Therapy Technologies Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Cell Therapy Technologies Market, Segmentation by Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Cell Therapy Technologies Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Cell Therapy Technologies Market
29.1. Africa Cell Therapy Technologies Market Overview
29.2. Africa Cell Therapy Technologies Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Cell Therapy Technologies Market, Segmentation by Cell Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Cell Therapy Technologies Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Cell Therapy Technologies Market Competitive Landscape and Company Profiles
30.1. Cell Therapy Technologies Market Competitive Landscape
30.2. Cell Therapy Technologies Market Company Profiles
30.2.1. Lonza Group AG
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Thermo Fisher Scientific Inc
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Merck KGaA
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Terumo Corporation
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Danaher Corporation
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Cell Therapy Technologies Market Other Major and Innovative Companies
31.1. Fresenius Medical Care AG & Co. KGaA
31.2. Fujifilm Holdings Corporation
31.3. Sartorius AG
31.4. Becton Dickinson and Company
31.5. Avantor Inc.
31.6. Cellular Biomedicine Group
31.7. CORESTEM
31.8. Astellas Pharma Inc
31.9. Anterogen Co. Ltd
31.10. Arce Therapeutics
31.11. CARsgen Therapeutics
31.12. Huadong Medicine
31.13. Co.Don AG
31.14. AstraZeneca
31.15. Neogene Therapeutics
32. Global Cell Therapy Technologies Market Competitive Benchmarking33. Global Cell Therapy Technologies Market Competitive Dashboard34. Key Mergers and Acquisitions in the Cell Therapy Technologies Market
35. Cell Therapy Technologies Market Future Outlook and Potential Analysis
35.1 Cell Therapy Technologies Market in 2028 - Countries Offering Most New Opportunities
35.2 Cell Therapy Technologies Market in 2028 - Segments Offering Most New Opportunities
35.3 Cell Therapy Technologies Market in 2028 - Growth Strategies
35.3.1 Market Trend-based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic and Forecast Inflation Rates
36.4. Research Inquiries
36.5. About the Analyst
36.6. Copyright and Disclaimer

Executive Summary

Cell Therapy Technologies Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell therapy technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia-Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis.
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for cell therapy technologies? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of COVID-19 on supply chains and consumption patterns.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Report Scope

Markets Covered:
1) By Product: Consumables; Equipment; Systems and Software
2) By Cell Type: T-Cells; Stem Cells; Other Cells
3) By Process: Cell Processing; Cell Preservation, Distribution and Handling; Process Monitoring and Quality Control
4) By End-user: Life Science Companies; Research Institutes and Cell Banks

Key Companies Mentioned: Lonza Group AG; Thermo Fisher Scientific Inc; Merck KGaA; Terumo Corporation; Danaher Corporation

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes

Delivery Format: PDF, Word and Excel Data Dashboard

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Lonza Group AG
  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • Terumo Corporation
  • Danaher Corporation
  • Fresenius Medical Care AG & Co. KGaA
  • Fujifilm Holdings Corporation
  • Sartorius AG
  • Becton Dickinson and Company
  • Avantor Inc.
  • Cellular Biomedicine Group
  • CORESTEM
  • Astellas Pharma Inc
  • Anterogen Co. Ltd
  • Arce Therapeutics
  • CARsgen Therapeutics
  • Huadong Medicine
  • Co.Don AG
  • AstraZeneca
  • Neogene Therapeutics
  • GammaDelta Therapeutics Limited
  • Nightstar
  • SOTIO
  • Accell Clinical Research
  • Genestack
  • Novartis AG
  • Pfizer
  • Celgene Corporation
  • Johnson & Johnson
  • F. Hoffmann-La Roche Ltd
  • Bayer AG
  • Gilead Sciences
  • Juno Therapeutics
  • Allogene Therapeutics
  • Bluebird Bio
  • Amgen
  • Regen BioPharma
  • Bellicum
  • Amgen Brazil
  • GlaxoSmithKline plc
  • Biogen Brazil
  • Takeda Pharmaceutical Company Limited
  • Pfizer S.R.L
  • Biotchpharma
  • BrainStorm Cell Therapeutics
  • Pluristem
  • Bayer East Africa Ltd
  • Adcock Ingram
  • Next BioSciences
  • CryoSave
  • BioHeart
  • Stem Cell Technologies.

Methodology

Loading
LOADING...

Table Information